Literature DB >> 18389351

Factors influencing HIV vaccine community engagement in the urban South.

Paula M Frew1, Carlos del Rio, Sarah Clifton, Matthew Archibald, Joseph T Hormes, Mark J Mulligan.   

Abstract

The purpose of this exploratory study was to examine personal characteristics, socio-environmental conditions, and motivational factors that potentially influence HIV vaccine research community engagement. Specifically, the study identified predictive aspects that may aid in future community program development on HIV vaccine issues. A cross-sectional survey consisting of evaluative measures, demographics, social interaction, and health information-seeking behaviors was conducted. Participants were a diverse group of 452 adults (>or=18 years) at HIV vaccine awareness-building and community education gatherings in Atlanta. The sample included large numbers of women (n=251) and minorities (n=224). In multivariate analysis, the overall logistic regression model was significant, with a resulting coefficient of determination (Nagelkerke R(2)) of .505. Highly significant factors included an excellent activity/event rating (log odds beta = 4.521, P< .001), White race (beta= -.835, P= .005), greater educational attainment (beta= .725, P= .011), travel distance (beta = 1.186, P= .002), and excellent perception of the study site (beta=2.131, P< .001). Subgroup analyses by gender and race revealed similar findings. These data demonstrate the importance of building a favorable study site image and gaining familiarity in the community to aid in the promotion of HIV vaccine research on an ongoing basis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18389351     DOI: 10.1007/s10900-008-9086-8

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  37 in total

1.  African-American participation in clinical trials: situating trust and trustworthiness.

Authors:  L M Crawley
Journal:  J Natl Med Assoc       Date:  2001-12       Impact factor: 1.798

2.  Distrust, race, and research.

Authors:  Giselle Corbie-Smith; Stephen B Thomas; Diane Marie M St George
Journal:  Arch Intern Med       Date:  2002-11-25

3.  Theory and practice in health communication campaigns: a critical interrogation.

Authors:  Mohan J Dutta-Bergman
Journal:  Health Commun       Date:  2005

4.  Towards a science of community engagement.

Authors:  Peter A Newman
Journal:  Lancet       Date:  2006-01-28       Impact factor: 79.321

5.  Community participation in AIDS vaccine trials: empowerment or science?

Authors:  Leslie Swartz; Ashraf Kagee
Journal:  Soc Sci Med       Date:  2006-05-16       Impact factor: 4.634

6.  Why blacks do not take part in HIV vaccine trials.

Authors:  Demetrius L Moutsiakis; P Nancy Chin
Journal:  J Natl Med Assoc       Date:  2007-03       Impact factor: 1.798

7.  Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.

Authors:  Jacqueline M O'Connell; Robert S Hogg; Keith Chan; Steffanie A Strathdee; Nancy McLean; Steve L Martindale; Brian Willoughby; Robert Remis
Journal:  J Acquir Immune Defic Syndr       Date:  2002-12-15       Impact factor: 3.731

8.  The role of community advisory boards: involving communities in the informed consent process.

Authors:  R P Strauss; S Sengupta; S C Quinn; J Goeppinger; C Spaulding; S M Kegeles; G Millett
Journal:  Am J Public Health       Date:  2001-12       Impact factor: 9.308

9.  Assessing the attitudes, knowledge, and awareness of HIV vaccine research among adults in the United States.

Authors:  Mary A Allen; Thomas S Liang; Thomas La Salvia; Brian Tjugum; Robert J Gulakowski; Matthew Murguía
Journal:  J Acquir Immune Defic Syndr       Date:  2005-12-15       Impact factor: 3.731

10.  Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team.

Authors:  B A Koblin; S Holte; B Lenderking; P Heagerty
Journal:  J Acquir Immune Defic Syndr       Date:  2000-08-15       Impact factor: 3.731

View more
  13 in total

1.  Promoting HIV Vaccine Research in African American Communities: Does the Theory of Reasoned Action Explain Potential Outcomes of Involvement?

Authors:  Paula M Frew; Matthew Archibald; Nina Martinez; Carlos del Rio; Mark J Mulligan
Journal:  Challenge (Atlanta Ga)       Date:  2007

2.  Factors mediating seasonal and influenza A (H1N1) vaccine acceptance among ethnically diverse populations in the urban south.

Authors:  Paula M Frew; Julia E Painter; Brooke Hixson; Carolyn Kulb; Kathryn Moore; Carlos del Rio; Alejandra Esteves-Jaramillo; Saad B Omer
Journal:  Vaccine       Date:  2012-04-23       Impact factor: 3.641

3.  Socioecological influences on community involvement in HIV vaccine research.

Authors:  Paula M Frew; Matthew Archibald; Brooke Hixson; Carlos del Rio
Journal:  Vaccine       Date:  2011-06-29       Impact factor: 3.641

4.  Factors associated with participation by African Americans in a study of the genetics of glaucoma.

Authors:  Rupin Parikh; Laura O'Keefe; Rebecca Salowe; Makayla Mccoskey; Wei Pan; Prithvi Sankar; Eydie Miller-Ellis; Victoria Addis; Amanda Lehman; Maureen Maguire; Joan O'Brien
Journal:  Ethn Health       Date:  2017-07-01       Impact factor: 2.772

5.  Time will tell: community acceptability of HIV vaccine research before and after the "Step Study" vaccine discontinuation.

Authors:  Paula M Frew; Mark J Mulligan; Su-I Hou; Kayshin Chan; Carlos del Rio
Journal:  Open Access J Clin Trials       Date:  2010-09-01

6.  The likelihood of participation in clinical trials can be measured: the Clinical Research Involvement Scales.

Authors:  Paula M Frew; Su-I Hou; Marsha Davis; Kayshin Chan; Takeia Horton; Justin Shuster; Brooke Hixson; Carlos del Rio
Journal:  J Clin Epidemiol       Date:  2010-03-19       Impact factor: 6.437

7.  The Community Liaison Program: a health education pilot program to increase minority awareness of HIV and acceptance of HIV vaccine trials.

Authors:  R T Kelley; A Hannans; G L Kreps; K Johnson
Journal:  Health Educ Res       Date:  2012-02-10

8.  An extended model of reasoned action to understand the influence of individual- and network-level factors on African Americans' participation in HIV vaccine research.

Authors:  Paula M Frew; Matthew Archibald; Dazon Dixon Diallo; Su-I Hou; Takeia Horton; Kayshin Chan; Mark J Mulligan; Carlos del Rio
Journal:  Prev Sci       Date:  2010-06

9.  Representation of Latinos and Blacks in screening for and enrollment into preventive HIV vaccine trials in New York City.

Authors:  Tanya M Ellman; Kellie Hawkins; Jorge Benitez; Ramon Negron; Steven Chang; Steven Palmer; Verna Robertson; Mary Ann Chiasson; Magdalena E Sobieszczyk
Journal:  Vaccine       Date:  2015-10-11       Impact factor: 3.641

10.  School-level perceptions and enforcement of the elimination of nonmedical exemptions to vaccination in California.

Authors:  Taylor A Holroyd; Amanda C Howa; Tina M Proveaux; Paul L Delamater; Nicola P Klein; Alison M Buttenheim; Rupali J Limaye; Saad B Omer; Daniel A Salmon
Journal:  Hum Vaccin Immunother       Date:  2021-01-25       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.